This HTML5 document contains 190 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n11http://linked.opendata.cz/resource/sukl/roa/
n2http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/
dctermshttp://purl.org/dc/terms/
n3http://linked.opendata.cz/ontology/sukl/
n17http://www.emea.europa.eu/docs/cs_CZ/document_library/EPAR_-_Product_Information/human/000332/
n21http://linked.opendata.cz/resource/sukl/specialization-restriction/
n9http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0149597/price-of-originator/
skoshttp://www.w3.org/2004/02/skos/core#
n20http://linked.opendata.cz/resource/sukl/indgroup/
n8http://linked.opendata.cz/resource/sukl/packing/
n7http://linked.opendata.cz/resource/sukl/company/
n4http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0149597/reimbursement/
n12http://linked.opendata.cz/resource/sukl/active-ingredient/
n16http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0149597/
n10http://linked.opendata.cz/resource/sukl/specialization-restriction/http://linked.opendata.cz/ontology/odcs/tabular/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0149597/core-reimbursement/
n19http://linked.opendata.cz/resource/sukl/registration-state/
n15http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0149597/price/
xsdhhttp://www.w3.org/2001/XMLSchema#
n14http://linked.opendata.cz/resource/sukl/df/
n13http://linked.opendata.cz/resource/atc/

Statements

Subject Item
n2:0149597
rdf:type
n3:MedicinalProductPackaging
dcterms:title
ARANESP 300 MIKROGRAMŮ
skos:notation
0149597
n3:hasATCCode
n13:B03XA02
n3:hasActiveIngredient
n12:DARBEPOETINUM-ALFA
n3:hasDefinedDailyDose
n16:ddd
n3:hasDosageForm
n14:INJ-SOL-SDR-IVN
n3:hasPackagingSize
1X0.6ML II
n3:hasPacking
n8:ISP
n3:hasRegistrationHolder
n7:AEBNL
n3:hasRegistrationState
n19:R
n3:hasRouteOfAdministration
n11:SDR-IVN
n3:hasStrength
500RG/ML
n3:hasIndicationGroup
n20:12
n3:hasSpecializationRestriction
n10:blank-cell n21:PED n21:ONK n21:NEF n21:INT n21:HEM
n3:containsDefinedDailyDoses
66.6667022705078125
n3:hasRegistrationCode
EU/1/01/185/096
n3:hasTitleSupplement
SDR+IVN INJ SOL 1X0.6ML II
n3:containsUsualTherapeuticalDailyDoses
66.6667
n3:hasBreakMarketingDate
2014-01-01+01:00
n3:hasCoreReimbursementSpecification
n5:2014-05-01 n5:2014-06-01 n5:2014-03-01 n5:2014-04-01 n5:2014-07-03 n5:2014-08-01 n5:2014-06-13 n5:2014-07-01 n5:2013-09-01 n5:2013-10-01 n5:2013-08-01 n5:2013-08-03 n5:2014-01-01 n5:2014-02-01 n5:2013-11-01 n5:2013-12-01 n5:2013-02-01 n5:2013-03-01 n5:2013-01-01 n5:2013-01-05 n5:2013-06-01 n5:2013-07-01 n5:2013-04-01 n5:2013-05-01 n5:2015-04-01 n5:2015-04-02 n5:2015-02-01 n5:2015-03-01 n5:2015-07-01 n5:2015-07-02 n5:2015-05-01 n5:2015-06-01 n5:2014-10-02 n5:2014-11-01 n5:2014-09-01 n5:2014-10-01 n5:2015-01-01 n5:2015-01-13 n5:2014-11-19 n5:2014-12-01
n3:hasIndicationRestriction
P
n3:hasPriceOfOriginatorSpecification
n9:2013-06-01 n9:2013-07-01 n9:2013-04-01 n9:2013-05-01 n9:2013-02-01 n9:2013-03-01 n9:2013-01-01 n9:2013-01-05 n9:2014-01-01 n9:2014-02-01 n9:2013-11-01 n9:2013-12-01 n9:2013-09-01 n9:2013-10-01 n9:2013-08-01 n9:2013-08-03 n9:2014-07-03 n9:2014-08-01 n9:2014-06-13 n9:2014-07-01 n9:2014-05-01 n9:2014-06-01 n9:2014-03-01 n9:2014-04-01 n9:2015-01-01 n9:2015-01-13 n9:2014-11-19 n9:2014-12-01 n9:2014-10-02 n9:2014-11-01 n9:2014-09-01 n9:2014-10-01 n9:2015-07-01 n9:2015-07-02 n9:2015-05-01 n9:2015-06-01 n9:2015-04-01 n9:2015-04-02 n9:2015-02-01 n9:2015-03-01
n3:hasPriceSpecification
n15:2013-08-01 n15:2013-08-03 n15:2013-09-01 n15:2013-10-01 n15:2013-11-01 n15:2013-12-01 n15:2014-01-01 n15:2014-02-01 n15:2014-03-01 n15:2014-04-01 n15:2014-05-01 n15:2014-06-01 n15:2014-06-13 n15:2014-07-01 n15:2014-07-03 n15:2014-08-01 n15:2014-09-01 n15:2014-10-01 n15:2014-10-02 n15:2014-11-01 n15:2014-11-19 n15:2014-12-01 n15:2015-01-01 n15:2015-01-13 n15:2015-02-01 n15:2015-03-01 n15:2015-04-01 n15:2015-04-02 n15:2015-05-01 n15:2015-06-01 n15:2015-07-01 n15:2015-07-02 n15:2013-01-01 n15:2013-01-05 n15:2013-02-01 n15:2013-03-01 n15:2013-04-01 n15:2013-05-01 n15:2013-06-01 n15:2013-07-01
n3:hasReimbursementSpecification
n4:2014-10-02 n4:2014-11-01 n4:2014-09-01 n4:2014-10-01 n4:2015-01-01 n4:2015-01-13 n4:2014-11-19 n4:2014-12-01 n4:2015-04-01 n4:2015-04-02 n4:2015-02-01 n4:2015-03-01 n4:2015-07-01 n4:2015-07-02 n4:2015-05-01 n4:2015-06-01 n4:2013-02-01 n4:2013-03-01 n4:2013-01-01 n4:2013-01-05 n4:2013-06-01 n4:2013-07-01 n4:2013-04-01 n4:2013-05-01 n4:2013-09-01 n4:2013-10-01 n4:2013-08-01 n4:2013-08-03 n4:2014-01-01 n4:2014-02-01 n4:2013-11-01 n4:2013-12-01 n4:2014-05-01 n4:2014-06-01 n4:2014-03-01 n4:2014-04-01 n4:2014-07-03 n4:2014-08-01 n4:2014-06-13 n4:2014-07-01
n3:hasResumedMarketingDate
2011-02-01+01:00
n3:hasUsualTherapeuticalDailyDose
n16:utdd
n3:spcFile
http%3A%2F%2Fwww.emea.europa.eu%2Fdocs%2Fcs_CZ%2Fdocument_library%2FEPAR_-_Product_Information%2Fhuman%2F000332%2FWC500026149.pdf
n3:spcUri
n17:WC500026149.pdf